Publication Cover
Archives of Physiology and Biochemistry
The Journal of Metabolic Diseases
Volume 121, 2015 - Issue 4
594
Views
19
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Does 8 weeks of strenuous bicycle exercise improve diabetes-related inflammatory cytokines and free fatty acids in type 2 diabetes patients and individuals at high-risk of metabolic syndrome?

, , &
Pages 129-138 | Received 22 Jun 2015, Accepted 07 Aug 2015, Published online: 15 Oct 2015

References

  • Arita Y, Kihara S, Ouchi N, et al. (1999). Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun, 257(1):79–83
  • Astrup A, Finer N. (2000). Redefining type 2 diabetes: “diabesity” or “obesity dependent diabetes mellitus”? Obes Rev, 1(2):57–9
  • Babraj JA, Vollaard NB, Keast C, et al. (2009). Extremely short duration high intensity interval training substantially improves insulin action in young healthy males. BMC Endocr Disord, 9:3
  • Balagopal P, George D, Yarandi H, et al. (2005). Reversal of obesity-related hypoadiponectinemia by lifestyle intervention: A controlled, randomized study in obese adolescents. J Clin Endocrinol Metab, 90(11):6192–7
  • Balducci S, Zanuso S, Nicolucci A, et al. (2010). Anti-inflammatory effect of exercise training in subjects with type 2 diabetes and the metabolic syndrome is dependent on exercise modalities and independent of weight loss. Nutr Metab Cardiovasc Dis, 20(8):608–17
  • Bastard JP, Lagathu C, Caron M, Capeau J. (2007). Point-counterpoint: Interleukin-6 does/does not have a beneficial role in insulin sensitivity and glucose homeostasis. J Appl Physiol (1985), 102(2):821–2 (author reply 825)
  • Bjorndal B, Burri L, Staalesen V, et al. (2011). Different adipose depots: Their role in the development of metabolic syndrome and mitochondrial response to hypolipidemic agents. J Obes, 2011:490650
  • Boudou P, Sobngwi E, Mauvais-Jarvis F, et al. (2003). Absence of exercise-induced variations in adiponectin levels despite decreased abdominal adiposity and improved insulin sensitivity in type 2 diabetic men. Eur J Endocrinol, 149(5):421–4
  • Considine RV, Sinha MK, Heiman ML, et al. (1996). Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med, 334(5):292–5
  • de Souza Batista CM, Yang RZ, Lee MJ, et al. (2007). Omentin plasma levels and gene expression are decreased in obesity. Diabetes, 56(6):1655–61
  • Despres JP, Pouliot MC, Moorjani S, et al. (1991). Loss of abdominal fat and metabolic response to exercise training in obese women. Am J Physiol, 261(2 Pt 1):E159–67
  • Despres JP, Lemieux I. (2006). Abdominal obesity and metabolic syndrome. Nature, 444(7121):881–7
  • Donath MY, Shoelson SE. (2011). Type 2 diabetes as an inflammatory disease. Nat Rev Immunol, 11(2):98–107
  • Ervin RB. (2009). Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United States, 2003–2006. Natl Health Stat Report, 13(13):1–7
  • Fatouros IG, Tournis S, Leontsini D, et al. (2005). Leptin and adiponectin responses in overweight inactive elderly following resistance training and detraining are intensity related. J Clin Endocrinol Metab, 90(11):5970–77
  • Ford ES. (2002). Does exercise reduce inflammation? Physical activity and C-reactive protein among U.S. adults. Epidemiology, 13(5):561–8
  • Frayn KN, Tan GD, Karpe F. (2007). Adipose tissue: A key target for diabetes pathophysiology and treatment? Horm Metab Res, 39(10):739–42
  • Frystyk J, Tarnow L, Hansen TK, et al. (2005). Increased serum adiponectin levels in type 1 diabetic patients with microvascular complications. Diabetologia, 48(9):1911–18
  • Garcia C, Feve B, Ferre P, et al. (2010). Diabetes and inflammation: Fundamental aspects and clinical implications. Diabetes Metab, 36(5):327–338
  • Giannopoulou I, Fernhall B, Carhart R, et al. (2005). Effects of diet and/or exercise on the adipocytokine and inflammatory cytokine levels of postmenopausal women with type 2 diabetes. Metabolism, 54(7):866–75
  • Hara T, Fujiwara H, Nakao H, et al. (2005). Body composition is related to increase in plasma adiponectin levels rather than training in young obese men. Eur J Appl Physiol, 94(5–6):520–26
  • Hickey MS, Houmard JA, Considine RV, et al. (1997). Gender-dependent effects of exercise training on serum leptin levels in humans. Am J Physiol, 272(4 Pt 1):E562–6
  • Hotamisligil GS, Shargill NS, Spiegelman BM. (1993). Adipose expression of tumor necrosis factor-alpha: Direct role in obesity-linked insulin resistance. Science, 259(5091):87–91
  • Hulver MW, Zheng D, Tanner CJ, et al. (2002). Adiponectin is not altered with exercise training despite enhanced insulin action. Am J Physiol Endocrinol Metab, 283(4):E861–5
  • IDF (International Diabetes Federation). (2013). IDF Diabetes Atlas. Brussels, Belgium: IDF
  • Ishii T, Yamakita T, Yamagami K, et al. (2001). Effect of exercise training on serum leptin levels in type 2 diabetic patients. Metabolism, 50(10):1136–40
  • James PT, Rigby N, Leach R (International Obesity Task Force). (2004). The obesity epidemic, metabolic syndrome and future prevention strategies. Eur J Cardiovasc Prev Rehabil, 11(1):3–8
  • Kadoglou NP, Perrea D, Iliadis F, et al. (2007a). Exercise reduces resistin and inflammatory cytokines in patients with type 2 diabetes. Diabetes Care, 30(3):719–21
  • Kadoglou NP, Iliadis F, Liapis CD, et al. (2007b). Beneficial effects of combined treatment with rosiglitazone and exercise on cardiovascular risk factors in patients with type 2 diabetes. Diabetes Care, 30(9):2242–4
  • Kadoglou NP, Iliadis F, Angelopoulou N, et al. (2007c). The anti-inflammatory effects of exercise training in patients with type 2 diabetes mellitus. Eur J Cardiovasc Prev Rehabil, 14(6):837–43
  • Kondo T, Kobayashi I, Murakami M. (2006). Effect of exercise on circulating adipokine levels in obese young women. Endocr J, 53(2):189–95
  • Lazar MA. (2007). Resistin- and obesity-associated metabolic diseases. Horm Metab Res, 39(10):710–16
  • Lindberg S, Jensen JS, Bjerre M, et al. (2015). Adiponectin, type 2 diabetes and cardiovascular risk. Eur J Prev Cardiol, 22(3):276–83
  • Madsen SM, Thorup AC, Overgaard K, Jeppesen PB. (2015). High intensity interval training improves glycaemic control and pancreatic β cell function of type 2 diabetes patients. PLoS One, 10(8):e0133286
  • Marcell TJ, McAuley KA, Traustadottir T, Reaven PD. (2005). Exercise training is not associated with improved levels of C-reactive protein or adiponectin. Metabolism, 54(4):533–41
  • Matsuzawa Y. (2005). White adipose tissue and cardiovascular disease. Best Pract Res Clin Endocrinol Metab, 19(4):637–47
  • Matthews JN, Altman DG, Campbell MJ, Royston P. (1990). Analysis of serial measurements in medical research. BMJ, 300(6719):230–35
  • Maury E, Brichard SM. (2010). Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrinol, 314(1):1–16
  • Mauriege P, Marette A, Atgie C, et al. (1995). Regional variation in adipose tissue metabolism of severely obese premenopausal women. J Lipid Res, 36(4):672–84
  • Mensink M, Blaak EE, van Baak MA, et al. (2001). Plasma free Fatty Acid uptake and oxidation are already diminished in subjects at high risk for developing type 2 diabetes. Diabetes, 50(11):2548–54
  • Middlebrooke AR, Elston LM, Macleod KM, et al. (2006). Six months of aerobic exercise does not improve microvascular function in type 2 diabetes mellitus. Diabetologia, 49(10):2263–71
  • Mittendorfer B, Fields DA, Klein S. (2004). Excess body fat in men decreases plasma fatty acid availability and oxidation during endurance exercise. Am J Physiol Endocrinol Metab, 286(3):E354–62
  • Miyaki A, Maeda S, Choi Y, et al. (2012). Habitual aerobic exercise increases plasma pentraxin 3 levels in middle-aged and elderly women. Appl Physiol Nutr Metab, 37(5):907–11
  • Mokdad AH, Ford ES, Bowman BA, et al. (2001). Prevalence of obesity, diabetes, and obesity-related health risk factors 2001. JAMA, 289(1):76–9
  • Moro C, Pillard F, de Glisezinski I, et al. (2008). Exercise-induced lipid mobilization in subcutaneous adipose tissue is mainly related to natriuretic peptides in overweight men. Am J Physiol Endocrinol Metab, 295(2):E505–13
  • Mourier A, Gautier JF, De Kerviler E, et al. (1997). Mobilization of visceral adipose tissue related to the improvement in insulin sensitivity in response to physical training in NIDDM. Effects of branched-chain amino acid supplements. Diabetes Care, 20(3):385–91
  • Nakajima T, Kurano M, Hasegawa T, et al. (2010). Pentraxin3 and high-sensitive C-reactive protein are independent inflammatory markers released during high-intensity exercise. Eur J Appl Physiol, 110(5):905–13
  • Oberbach A, Tonjes A, Kloting N, et al. (2006). Effect of a 4 week physical training program on plasma concentrations of inflammatory markers in patients with abnormal glucose tolerance. Eur J Endocrinol, 154(4):577–85
  • Ostrowski K, Rohde T, Asp S, et al. (1999). Pro- and anti-inflammatory cytokine balance in strenuous exercise in humans. J Physiol, 515(Pt 1):287–91
  • Ozbay LA, Moller N, Juhl C, et al. (2012). Calcineurin inhibitors acutely improve insulin sensitivity without affecting insulin secretion in healthy human volunteers. Br J Clin Pharmacol, 73(4):536–45
  • Pan HY, Guo L, Li Q. (2010). Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes. Diabetes Res Clin Pract, 88(1):29–33
  • Pedersen BK. (2006). The anti-inflammatory effect of exercise: Its role in diabetes and cardiovascular disease control. Essays Biochem, 42:105–17
  • Pedersen BK, Febbraio MA. (2008). Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physiol Rev, 88(4):1379–406
  • Pickup JC, Mattock MB, Chusney GD, Burt D. (1997). NIDDM as a disease of the innate immune system: Association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia, 40(11):1286–92
  • Perusse L, Collier G, Gagnon J, et al. (1997). Acute and chronic effects of exercise on leptin levels in humans. J Appl Physiol (1985), 83(1):5–10
  • Rauramaa R, Halonen P, Vaisanen SB, et al. (2004). Effects of aerobic physical exercise on inflammation and atherosclerosis in men: The DNASCO Study: A six-year randomized, controlled trial. Ann Intern Med, 140(12):1007–14
  • Reseland JE, Anderssen SA, Solvoll K, et al. (2001). Effect of long-term changes in diet and exercise on plasma leptin concentrations. Am J Clin Nutr, 73(2):240–45
  • Ridker PM, Hennekens CH, Buring JE, Rifai N. (2000). C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med, 342(12):836–43
  • Roden M, Stingl H, Chandramouli V, et al. (2000). Effects of free fatty acid elevation on postabsorptive endogenous glucose production and gluconeogenesis in humans. Diabetes, 49(5):701–7
  • Ross R, Janssen I, Dawson J, et al. (2004). Exercise-induced reduction in obesity and insulin resistance in women: A randomized controlled trial. Obes Res, 12(5):789–98
  • Ross R, Bradshaw AJ. (2009). The future of obesity reduction: Beyond weight loss. Nat Rev Endocrinol, 5(6):319–25
  • Ryan AS, Nicklas BJ, Berman DM, Elahi D. (2003). Adiponectin levels do not change with moderate dietary induced weight loss and exercise in obese postmenopausal women. Int J Obes Relat Metab Disord, 27(9):1066–71
  • Sabio G, Das M, Mora A, et al. (2008). A stress signaling pathway in adipose tissue regulates hepatic insulin resistance. Science, 322(5907):1539–43
  • Saremi A, Asghari M, Ghorbani A. (2010). Effects of aerobic training on serum omentin-1 and cardiometabolic risk factors in overweight and obese men. J Sports Sci, 28(9):993–8
  • Schwartz RS, Shuman WP, Larson V, et al. (1991). The effect of intensive endurance exercise training on body fat distribution in young and older men. Metabolism, 40(5):545–51
  • Shaw K, Gennat H, O'Rourke P, Del Mar C. (2006). Exercise for overweight or obesity. Cochrane Database Syst Rev, 4(4):CD003817
  • Shoelson SE, Herrero L, Naaz A. (2007). Obesity, inflammation, and insulin resistance. Gastroenterology, 132(6):2169–80
  • Shojaee-Moradie F, Baynes KC, Pentecost C, et al. (2007). Exercise training reduces fatty acid availability and improves the insulin sensitivity of glucose metabolism. Diabetologia, 50(2):404–13
  • Skoog T, Dichtl W, Boquist S, et al. (2002). Plasma tumour necrosis factor-alpha and early carotid atherosclerosis in healthy middle-aged men. Eur Heart J, 23(5):376–83
  • Steensberg A, Fischer CP, Keller C, et al. (2003). IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans. Am J Physiol Endocrinol Metab, 285(2):E433–7
  • Stich V, De Glisezinski I, Crampes F, et al. (2000). Activation of alpha(2)-adrenergic receptors impairs exercise-induced lipolysis in SCAT of obese subjects. Am J Physiol Regul Integr Comp Physiol, 279(2):R499–504
  • Tan BK, Adya R, Farhatullah S, et al. (2008). Omentin-1, a novel adipokine, is decreased in overweight insulin-resistant women with polycystic ovary syndrome: Ex vivo and in vivo regulation of omentin-1 by insulin and glucose. Diabetes, 57(4):801–8
  • Tchernof A, Despres JP. (2013). Pathophysiology of human visceral obesity: An update. Physiol Rev, 93(1):359–404
  • Wilmore JH, Despres JP, Stanforth PR, et al. (1999). Alterations in body weight and composition consequent to 20 wk of endurance training: The HERITAGE Family Study. Am J Clin Nutr, 70(3):346–52
  • Wu T, Gao X, Chen M, van Dam RM. (2009). Long-term effectiveness of diet-plus-exercise interventions vs diet-only interventions for weight loss: A meta-analysis. Obes Rev, 10(3):313–23
  • Yang RZ, Lee MJ, Hu H, et al. (2006). Identification of omentin as a novel depot-specific adipokine in human adipose tissue: Possible role in modulating insulin action. Am J Physiol Endocrinol Metab, 290(6):E1253–61
  • Zimmet P, Alberti KG, Shaw J. (2001). Global and societal implications of the diabetes epidemic. Nature, 414(6865):782–7
  • Zoppini G, Targher G, Zamboni C, et al. (2006). Effects of moderate-intensity exercise training on plasma biomarkers of inflammation and endothelial dysfunction in older patients with type 2 diabetes. Nutr Metab Cardiovasc Dis, 16(8):543–9

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.